Synthesis and bioactivity of substituted indan-1-ylideneaminoguanidine derivatives

European Journal of Medicinal Chemistry

Volumn 44, Issue 9, 2009, Pages 3771-3776

  Zhang, Rui ^a   Dong, Jin ^a   Xu, Yun gen ^a   Hua, Wei yi ^a   Wen, Na ^a   You, Qi dong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Alkylene aminoguanidine derivatives; Indan 1 one derivatives; NHE1 inhibitors; Synthesis

Indexed keywords

2 (5 METHOXYBENZIMIDAZOL 2 YLTHIO) 5 CHLORO 2,3 DIHYDROINDEN 1 YLIDENE AMINOGUANIDINE; CARIPORIDE; GUANIDINE DERIVATIVE; INDAN 1 YLIDINE AMINOGUANIDINE DERIVATIVE; INDANONE DERIVATIVE; SODIUM PROTON EXCHANGE PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; IC 50; MALE; NONHUMAN; RAT; REACTION ANALYSIS; REPERFUSION INJURY; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; CARDIOTONIC AGENTS; FEMALE; GUANIDINES; INDANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SODIUM-HYDROGEN ANTIPORTER;

EID: 67650438915     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.04.036     Document Type: Article

References (22)

1. Gross G.J., and Gumina R.J. Drugs Future 26 (2001) 253-260
2. Malo M.E., and Fliegel L. Can. J. Physiol. Pharmacol. 84 (2006) 1081-1095
3. Lei L., Xu Y.G., and Hua W.Y. Chin. Pharm. J. 40 (2005) 324-327
4. Slepkov E.R., Rainey J.K., Sykes B.D., and Fliegel L. Biochem. J. 401 (2007) 623-633
5. Izumi H., Torigoe T., Ishiguchi H., Uramoto H., Yoshida Y., Tanabe M., Ise T., Murakami T., Yoshida T., Nomoto M., and Kohno K. Cancer Treat. Rev. 29 (2003) 541-549
6. Leineweber K., Heusch G., and Schulz R. Cardiovasc. Drug Rev. 25 (2007) 123-131
7. Karmazyn M., Kilić A., and Javadov S. J. Mol. Cell. Cardiol. 44 (2008) 647-653
8. Karmazyn M., Sawyer M., and Fliegel L. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5 (2005) 323-335
9. Masereel B., Pochet L., and Laeckmann D. Eur. J. Med. Chem. 38 (2003) 547-554
10. Xu Y.G., Zhang R., and Hua W.Y. Prog. Pharm. Sci. 27 (2003) 264-269
11. Jiang X.M., Du P., Xu Y.G., Zhang D., Gong G.Q., and You Q.D. Chin. J. Org. Chem. 28 (2008) 2142-2148
12. Zhang R., Lei L., Xu Y.G., Hua W.Y., and Gong G.Q. Bioorg. Med. Chem. Lett. 17 (2007) 2430-2433
13. D. Mao, Y.G. Xu, X.P. Hu, G.M. Zhang, J. Dong, G.Q. Gong, Chem. Biodivers., in press, doi:10.1002/cbdv.200800268.
14. W.T. Xu, N. Jin, J. Xu, Y.G. Xu, Q.J. Wang, Q.D. You, Bioorg. Med. Chem. Lett., in press, doi:10.1016/j.bmcl.2009.04.079.
15. Kawamoto T., Kimura H., Kusumoto K., Fukumoto S., Shiraiahi M., Watanabe T., and Sawada H. Eur. J. Pharmacol. 420 (2001) 1-8
16. Kusumoto K., Igata H., Abe A., Ikeda S., Tsuboi A., Imamiya E., Fukumoto S., Shiraishi M., and Watanabe T. Br. J. Pharmacol. 135 (2002) 1995-2003
17. Yao S.W., Zhang R., Xu Y.G., Hua W.Y., and Wen N. Chin. J. Med. Chem. 17 (2007) 358-363
18. Otto M.C., Moore C., and Rooyen P.H. J. Chem. Soc., Perkin Trans. 1 (1985) 1793-1802
19. Zhang R., Xu Y.G., and Hua W.Y. Chin. J. Synth. Chem. 14 (2006) 463-467
20. Rosskopf D., Morgenstern E., Scholz W., Osswald U., and Siffert W. J. Hypertens. 9 (1991) 231-238
21. Laeckmann D., Rogister F., Dejardin J.V., Prosperi-Meys C., Geczy J., Delarge J., and Masereel B. Bioorg. Med. Chem. 10 (2002) 1793-1804
22. Lee B.H., Yi K.Y., Lee S., Lee S., and Yoo S. Eur. J. Pharmacol. 523 (2005) 101-108